ResApp Health Limited is engaged in developing digital healthcare solutions to assist doctors and patients to diagnose and manage respiratory disease. The Company offers a range of solutions, such as telehealth, clinical use, direct consumer and big data insights. The Company provides point of care diagnostic solutions for telehealth companies, which is integrated into their platforms. The Company is working on applications to provide clinical quality diagnostic tests and management tools directly to consumers and healthcare providers. The Company is developing smartphone medical applications for the diagnosis and management of respiratory disease. The Company's technology is based on the premise that cough and breathing sounds carry vital information on the state of the respiratory tract. ResApp measures the severity of a range of chronic and acute diseases, such as pneumonia, asthma, bronchiolitis and chronic obstructive pulmonary disease (COPD) using this insight.
|Vote ||Quantity||Free-Float||Company-owned shares||Total Float
|FIL Investment Management (Hong Kong) Ltd. ||85,783,372||
|FIL Investment Management (Australia) Ltd. ||4,063,174||
|BetaShares Capital Ltd. ||941,236||
|FIL Ltd. ||50,415||
Sector Enterprise Software
Connections : ResApp Health Limited